Conjugated
linoleic acid (CLA) is
not a single substance.
However, it is classified as an
omega-6 essential fatty acid,
existing as an isomer of linoleic acid.
The structure
of CLA is very similar to that of
linoleic acid, except that it has two
double bonds separated by a single
bond. Because Conjugated linoleic
acid has two double bonds, it is able
to have several different isomers.
The most important isomers include;
cis-9, cis-12, trans-10, and the
trans-11 isomers. The
formation of each isomer is
dependant upon the location of the
double bonds and the relationship in
the space of the arranged molecules.
Conjugated linoleic
acid is produced naturally in the
rumen of animals by the bacterial
metabolism of both linoleic and linolenic
acids. Animal sources and
dairy products represent the
greatest source of conjugated
linoleic acid. Gamma-linolenic acid
(GLA) is an Omega-3
essential fatty acid that is found
in the fatty acid fraction of some
plant seed oils, including those of
flax, borage, and hemp. GLA
may provide certain antithrombotic
and anti-inflammatory actions.
Conjugated linoleic
acid is readily absorbed by the
small intestine. Its exact mechanism
of action is not clearly understood.
Being a fatty acid, it may have a
role in the prostaglandin pathways similar to other fatty acids.
Most of what is known
about Conjugated linoleic acid comes
from in vivo animal and
in vitro studies.
Because of the promising
results yielded by such studies, human
research is currently being carried out. These trials will be able to provide
more concrete information about the
mechanisms of action regarding CLA,
within the
human body.
To date, Conjugated linoleic acid is believed to possess
anti-carcinogenic activity. It has
shown benefit for breast, colon,
prostate, lung, and melanoma
cancers. [1] It has been
equally effective as a modulator
of carcinogenesis at the stages of
initiation, promotion, and
progression. Conjugated linoleic
acid also has the ability to cause
or promote cell death (apoptosis).
Conjugated linoleic
acid is also thought to possess
certain
anti-diabetic and anti-atherogenic
properties. This nutrient may
also be able to decrease the total
percentage of body fat, while
promoting increases in lean muscle mass.
Conjugated linoleic
acid may provide an effective,
adjunctive treatment for certain cancers, diabetes,
cardiovascular disease, and obesity.
|
Conjugated Linoleic Acid Food Sources
|
Conjugated
linoleic acid can be found in
the meats of ruminant animals, such as sheep and cows. It is also found
in poultry, eggs, and dairy products that
have undergone specialized heat
treatment. Safflower and sunflower
oil are often processed to also contain
varying amounts of CLA. [2] Conjugated linoleic acid
is also found in the milk fats of certain
mammals.
Most of the
abovementioned food
sources cannot provide sufficient amounts of Conjugated linoleic acid, necessary for
achieving therapeutic benefit.
This is largely the result of the shift
in livestock care. Elevated Conjugated linoleic acid
are typical in those animals
fed on grasses, not on
grains. It is
believed that up to 75% of the
Conjugated linoleic acid is lost by
feeding grain instead of grass.
The most reliable and
abundant sources of Conjugated linoleic
acids are found in
nutritional/dietary supplements.
|
Conjugated Linoleic Acid Uses |
Conjugated linoleic
acid has been extensively researched for its
potential anti-cancer effects. t has been
shown to be anti-neoplastic and
pro-apoptotic towards most cancer
cell lines, excluding mammary
cancer. CLA is also effective against
the
increasing stages or severities of
malignancy. [3] It was far superior to linoleic acid
in its ability to prevent
the progression of certain cancers, as
well as with promoting
cancer cell death.
CLA may provide a useful
adjunctive treatment for breast
cancer. [4]
In study, Conjugated linoleic acid has exhibited
certain anti-estrogenic
properties and has also been effective
against the spread of estrogen
positive breast cancer cells. [5] CLA
was shown to block estrogen signals,
which are responsible for the proliferation of the cancer.
Conjugated linoleic acid has also shown some benefit
in bladder cancer. In
vitro studies suggest that Conjugated linoleic
acid may inhibit the growth of cancer
cells in the bladder, while also inducing cell death. [6]
Prostate cancer is
another cancer positively affected
by CLA, in vitro. Several
different isomers of Conjugated linoleic acid have been effective at
halting the cell cycle in cancerous
prostate cells and also furthering apoptosis. [7]
In addition to cancer
treatment, Conjugated linoleic
acid may also be useful in treatment
protocols for
cardiovascular diseases at large. It has been shown to decrease the
low-density lipoproteins (LDLs). LDL
is also known as the bad
cholesterol. Conjugated linoleic
acid can also provide substantial increases
in high-density lipoproteins, or HDLs. HDL is
referenced as the good form of cholesterol. [8]
By altering the lipid
metabolism and having positive
effects on total cholesterol levels, Conjugated linoleic acid
may prove to be an
effective treatment, and possibly
preventative supplement, against the
development of atherosclerosis. Conjugated linoleic acid
is purported to reduce early plaque formations,
common in the development of
atherosclerosis. [9]
Conjugated linoleic
acid may also be a practical adjunctive
treatment for Type II diabetes
mellitus. It has been proven
effective at altering the lipid
metabolism of non-insulin- dependent
diabetes mellitus (NIDDM) patients
by lowering LDL levels and providing
increases in HDL serum levels. [10]
In study, CLA has also been shown to increase sensitivity
to insulin in the tissues, which may
provide long-term reductions in the
elevated blood sugar levels often
exhibited in persons suffering from
this condition. [11]
CLA also impacts the
overall metabolism of glucose and
fatty acids in the body. This
may be especially relevant to
diabetics, as decreased levels of
triglyceride accumulation in the
liver are paralleled with lessening
one's risk of developing heart
disease. [12] In
the referenced study, body fat
deposition was also reduced as a
direct result of
Conjugated linoleic acid
supplementation.
|
Conjugated Linoleic Acid Dosages |
The standard dosage, recommended and used in
various clinical trials, remains at 1 - 2 grams of conjugated linoleic
acid per day. Dosages up to 6
grams per day have been used with no
side effects. [13]
|
Conjugated Linoleic Acid Toxicities and
Deficiencies |
There are no known
toxicities or interactions regarding
the past administration of CLA in or
out of study. Ongoing research
continues to further understand the
many physiological benefits
associated with
Conjugated linoleic acid
supplementation. By market
standards, CLA-containing
supplements are still considered newly marketed supplements.
In fact, human studies are just beginning
after promising results in initial animal and
in vitro
studies. It is certain that more
information concerning the mechanisms
and interactions in human subjects will
be made available within the next several years. Until that
time, it is advised to contact your
physician and inform him/her of any
supplements you may be using to
insure personal safety.
Because of the
lipid lowering effect of Conjugated
linoleic acid, there is a
potential for additive effects in
individuals who are taking a lipid
lowering medication for elevated
cholesterol levels.
|
Conjugated Linoleic Acid Products |
The following table lists various
products that contain a safe and
reliable source of Conjugated Linoleic Acid:
|
Manufacturer |
Ingredient |
Amount |
US RDA |
Learn More |
|
NSI |
Tonalin XS-CLA -- 1g |
1000mg |
-- |
Click Here
 |
|
GNC |
Conjugated Linoleic Acid
|
1000mg |
-- |
Click Here
 |
|
EAS |
Conjugated Linoleic
Acid |
1500mg |
-- |
Click Here
 |